Severe Preeclampsia in the Setting of Myasthenia Gravis

  • Lake A
  • Al Khabbaz A
  • Keeney R
N/ACitations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Myasthenia gravis (MG) is a rare autoimmune disease that leads to progressive muscle weakness and is common during female reproductive years. The myasthenic mother and her newborn must be observed carefully, as complications during all stages of pregnancy and the puerperium may arise suddenly. Preeclampsia is a common obstetrical condition for which magnesium sulfate is used for seizure prophylaxis. However, magnesium sulfate is strongly contraindicated in MG as it impairs already slowed nerve-muscle connections. Similarly, many first-line antihypertensive medications, including calcium channels blockers and β -blockers, may lead to MG exacerbation. This case describes the effective obstetrical management of a patient with MG who developed severe preeclampsia. The effective use of levetiracetam and various antihypertensive medications including intravenous labetalol is described. A review of the ten reported cases of MG complicated by preeclampsia is examined to aggregate observations of clinical care, with focus on delivery methods, anticonvulsants, and antihypertensive medications.

Cite

CITATION STYLE

APA

Lake, A. J., Al Khabbaz, A., & Keeney, R. (2017). Severe Preeclampsia in the Setting of Myasthenia Gravis. Case Reports in Obstetrics and Gynecology, 2017, 1–5. https://doi.org/10.1155/2017/9204930

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free